TOMI Environmental Solutions Secures Order from ARES Distribution
FREDERICK, Md., Aug. 11, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced that it has received a significant order from , a global distributor of scientific and medical equipment and products.
This is the fourth order the Company has received for its recently launched SteraMist Integration System (SIS) platform of products. The order is for a biomedical research university located in Coral Gables, Florida, and is fast-tracked with an anticipated delivery set for late 2025.
“Securing this order is a testament to our commitment to innovation and collaboration within the sterilization technology space,” said Elissa J. Shane, Chief Operating Officer of TOMI Environmental Solutions. “Each new project contributes valuable insights into the workflow optimization of our SteraMist iHP technology and its automation capabilities. Our partnership with ARES Distribution has been invaluable, and we are excited to continue developing and providing cutting-edge solutions that enhance safety and efficiency in critical environments.”
“We are pleased with the traction that our recently launched SIS platform of products is getting in the marketplace,” commented Elissa J. Shane. “Contamination control and disinfection are critical in research and healthcare settings, and we look forward to continuing to collaborate with a broadening base of manufacturers committed to enhancing quality and safety standards.”
TOMI™ Environmental Solutions, Inc.: Innovating for a safer world®
TOMI™ Environmental Solutions, Inc. (NASDAQ: ) is a global decontamination and infection prevention company, providing environmental solutions for disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT™ solution utilizes a low percentage hydrogen peroxide as its only active ingredient and uses patented ionized Hydrogen Peroxide (iHP™) technology in all SteraMist systems to create superior disinfection. TOMI products are designed to service a broad spectrum of use sites, including, but not limited to, hospitals and medical facilities, biosafety labs, pharmaceutical facilities, commercial and office buildings, schools, restaurants, meat and produce processing facilities, and police and fire departments.
For additional information, please visit or contact us at
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
This press release contains forward-looking statements that are based on current expectations, estimates, forecasts and projections of future performance based on management’s judgment, beliefs, current trends, and anticipated product performance. These forward-looking statements include, without limitation, statements relating to TOMI’s partnership with ARES Distribution and TOMI’s products to serve life science and university sectors. Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. These factors include, but are not limited to, our ability to maintain and manage growth and generate sales, our reliance on a single or a few products for a majority of revenues; the general business and economic conditions; and other risks as described in our SEC filings, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed by us with the SEC and other periodic reports we filed with the SEC. The information provided in this document is based upon the facts and circumstances known at this time. Other unknown or unpredictable factors or underlying assumptions subsequently proving to be incorrect could cause actual results to differ materially from those in the forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, or achievements. You should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today’s date, unless otherwise stated, and we undertake no duty to update such information, except as required under applicable law.
INVESTOR RELATIONS CONTACT:
John Nesbett/Rosalyn Christian
IMS Investor Relations
